World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
12822
World Ranking
11954
National Ranking
5130

Xiongbin Lu publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Xiongbin Lu sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 149 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Xiongbin Lu D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Xiongbin Lu sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 60 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Xiongbin Lu is a researcher affiliated with Indiana University in the United States. Their work spans the fields of biochemistry, genetics, molecular biology, and medicine, with a particular focus on molecular biology, oncology, immunology, cancer research, and biomedical engineering.

The scientist's research topics include:

  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • RNA modifications and cancer
  • Cancer, Hypoxia, and Metabolism
  • Epigenetics and DNA Methylation
  • Cancer Research and Treatments
  • Cancer Cells and Metastasis

Xiongbin Lu has contributed to a substantial number of publications, with key papers including:

  • "Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation" (2021), Journal of Clinical Investigation
  • "MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation" (2020), Journal of Clinical Investigation
  • "RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer" (2020), Gut
  • "Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia" (2021), Hepatology
  • "An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity" (2021), Nature Biomedical Engineering

The scientist frequently publishes in the following venues:

  • Cancer Research
  • Journal of Clinical Investigation
  • Nature Communications
  • Advanced Science
  • Nature Biomedical Engineering

Co-authorship is a notable aspect of their research output, with frequent collaborators including:

  • Xinna Zhang
  • Xiaoming He
  • Kevin Van der Jeught
  • Zhuolong Zhou
  • Yujing Li

Best Publications

  • p53 mutant mice that display early ageing-associated phenotypes

    Stuart D. Tyner;Sundaresan Venkatachalam;Jene Choi;Stephen Jones

  • Drug resistance and new therapies in colorectal cancer

    Kevin Van Der Jeught;Han Chen Xu;Yu Jing Li;Xiong Bin Lu

  • PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints

    Xiongbin Lu;Bonnie Nannenga;Lawrence A. Donehower

  • Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth.

    Lifeng Yang;Abhinav Achreja;Tsz Lun Yeung;Lingegowda S. Mangala

  • The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.

    Xiongbin Lu;Ou Ma;Thuy Ai Nguyen;Stephen N. Jones

  • Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance.

    Hai Wang;Zan Gao;Xuanyou Liu;Pranay Agarwal

  • Chitosan-Decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like Cells

    Wei Rao;Hai Wang;Jianfeng Han;Shuting Zhao

  • The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways

    Xiongbin Lu;Thuy Ai Nguyen;Sung Hwan Moon;Yolanda Darlington

  • Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.

    Hai Wang;Pranay Agarwal;Shuting Zhao;Ronald X. Xu

  • The ATM kinase induces microRNA biogenesis in the DNA damage response.

    Xinna Zhang;Guohui Wan;Guohui Wan;Franklin G. Berger;Xiaoming He

  • TP53 loss creates therapeutic vulnerability in colorectal cancer

    Yunhua Liu;Xinna Zhang;Cecil Han;Guohui Wan

  • Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway.

    Guohui Wan;Rohit Mathur;Xiaoxiao Hu;Yunhua Liu

  • USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1

    Xinna Zhang;Franklin G Berger;Jianhua Yang;Xiongbin Lu

  • Synthesis and characterization of thermally responsive Pluronic F127-chitosan nanocapsules for controlled release and intracellular delivery of small molecules.

    Wujie Zhang;Kyle Gilstrap;Laying Wu;K. C. Remant Bahadur

  • miR-203 Induces Oxaliplatin Resistance in Colorectal Cancer Cells by Negatively Regulating ATM Kinase

    Yunfei Zhou;Guohui Wan;Riccardo Spizzo;Cristina Ivan

  • Oncogenic Wip1 Phosphatase Is Inhibited by miR-16 in the DNA Damage Signaling Pathway

    Xinna Zhang;Guohui Wan;Sizolwenkosi Mlotshwa;Vicki Vance

  • miRNA response to DNA damage

    Guohui Wan;Rohit Mathur;Xiaoxiao Hu;Xinna Zhang

  • Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D

    Robert C. Castellino;Massimiliano De Bortoli;Xiongbin Lu;Sung Hwan Moon

  • A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation

    Guohui Wan;Xiaoxiao Hu;Yunhua Liu;Cecil Han

  • Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery.

    Pranay Agarwal;Hai Wang;Mingrui Sun;Jiangsheng Xu

Frequent Co-Authors

Lawrence A. Donehower
Lawrence A. Donehower Baylor College of Medicine
Jianhua Yu
Jianhua Yu City Of Hope National Medical Center
Yunlong Liu
Yunlong Liu Indiana University
Anil K. Sood
Anil K. Sood The University of Texas MD Anderson Cancer Center
Pulivarthi H. Rao
Pulivarthi H. Rao Baylor College of Medicine
John P. Fisher
John P. Fisher University of Maryland, College Park
Feng Guo
Feng Guo Pennsylvania State University
Lee M. Ellis
Lee M. Ellis The University of Texas MD Anderson Cancer Center
Stephen N. Jones
Stephen N. Jones University of Massachusetts Chan Medical School
George A. Calin
George A. Calin The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can open doors to many rewarding careers in science and healthcare. If you’re considering further specialization or flexible study options, there are several online pathways to launch or advance your career.

For those interested in nutrition science, accredited online degrees in nutrition can provide a strong foundation for roles such as nutritionist or food scientist. If you are committed to clinical fields, technology-driven programs such as ultrasound tech school offer practical skills in diagnostic imaging.

Cost is often a concern, but there are cheapest radiology tech programs available for students who want a more affordable route into healthcare. For advanced practice and leadership roles, consider enrolling in the top dietetics masters programs, where you’ll gain expertise in nutritional science and clinical dietetics.

Whether you’re starting out or seeking to upskill, online degrees provide flexible learning and a pathway to diverse careers in science, research, and healthcare.

Best Scientists Citing Xiongbin Lu

Trending Scientists

Recently Published Articles